Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.

Athan E, O'Brien DP, Legood R.

AIDS. 2010 Jul 31;24(12):1887-95. doi: 10.1097/QAD.0b013e32833b25ed.

PMID:
20543661
[PubMed - indexed for MEDLINE]
2.

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.

Antivir Ther. 2006;11(1):63-72.

PMID:
16518961
[PubMed - indexed for MEDLINE]
3.

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators.

Ann Intern Med. 2009 Aug 4;151(3):157-66. Epub 2009 Jul 20.

PMID:
19620143
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.

Medina Lara A, Kigozi J, Amurwon J, Muchabaiwa L, Nyanzi Wakaholi B, Mujica Mota RE, Walker AS, Kasirye R, Ssali F, Reid A, Grosskurth H, Babiker AG, Kityo C, Katabira E, Munderi P, Mugyenyi P, Hakim J, Darbyshire J, Gibb DM, Gilks CF; DART Trial Team.

PLoS One. 2012;7(4):e33672. doi: 10.1371/journal.pone.0033672. Epub 2012 Apr 24.

PMID:
22545079
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

Bishai D, Colchero A, Durack DT.

AIDS. 2007 Jun 19;21(10):1333-40.

PMID:
17545710
[PubMed - indexed for MEDLINE]
6.

Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis.

Hamers RL, Sawyer AW, Tuohy M, Stevens WS, Rinke de Wit TF, Hill AM; ART-A Consortium.

AIDS. 2012 Aug 24;26(13):1663-72.

PMID:
22695297
[PubMed - indexed for MEDLINE]
7.

When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.

Loubiere S, el Filal KM, Sodqi M, Loundou A, Luchini S, Cleary S, Moatti JP, Himmich H.

Antivir Ther. 2008;13(2):241-51.

PMID:
18505175
[PubMed - indexed for MEDLINE]
8.

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

Antivir Ther. 2003 Oct;8(5):379-84.

PMID:
14640384
[PubMed - indexed for MEDLINE]
9.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

PMID:
15703422
[PubMed - indexed for MEDLINE]
Free Article
10.

Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.

Bwire R, Nagelkerke NJ, Borgdorff MW.

Trop Med Int Health. 2006 Oct;11(10):1567-75.

PMID:
17002731
[PubMed - indexed for MEDLINE]
Free Article
11.

HIV antiretroviral treatment: early versus later.

Mauskopf J, Kitahata M, Kauf T, Richter A, Tolson J.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):562-9.

PMID:
16044008
[PubMed - indexed for MEDLINE]
12.

CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.

Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, Tappero JW, Ekwaru P, Kaharuza F, Mermin J.

BMJ. 2011 Nov 9;343:d6884. doi: 10.1136/bmj.d6884.

PMID:
22074713
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.

Diomandé FV, Bissagnéné E, Nkengasong JN, Maurice C, Monga B, Laga M, Nolan ML.

AIDS. 2003 Jul;17 Suppl 3:S87-93.

PMID:
14565614
[PubMed - indexed for MEDLINE]
14.

Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature.

Walensky RP, Ciaranello AL, Park JE, Freedberg KA.

Clin Infect Dis. 2010 Jul 1;51(1):85-92. doi: 10.1086/653119. Review.

PMID:
20482371
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates.

Mauskopf J, Lacey L, Kempel A, Simpson K.

Am J Manag Care. 1998 Jul;4(7):1004-12.

PMID:
10181990
[PubMed - indexed for MEDLINE]
Free Article
16.

The effect of community-based support services on clinical efficacy and health-related quality of life in HIV/AIDS patients in resource-limited settings in sub-Saharan Africa.

Kabore I, Bloem J, Etheredge G, Obiero W, Wanless S, Doykos P, Ntsekhe P, Mtshali N, Afrikaner E, Sayed R, Bostwelelo J, Hani A, Moshabesha T, Kalaka A, Mameja J, Zwane N, Shongwe N, Mtshali P, Mohr B, Smuts A, Tiam A.

AIDS Patient Care STDS. 2010 Sep;24(9):581-94. doi: 10.1089/apc.2009.0307.

PMID:
20799894
[PubMed - indexed for MEDLINE]
17.
18.

Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.

Koenig SP, Bang H, Severe P, Jean Juste MA, Ambroise A, Edwards A, Hippolyte J, Fitzgerald DW, McGreevy J, Riviere C, Marcelin S, Secours R, Johnson WD, Pape JW, Schackman BR.

PLoS Med. 2011 Sep;8(9):e1001095. doi: 10.1371/journal.pmed.1001095. Epub 2011 Sep 20.

PMID:
21949643
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.

Lancet. 1999 Sep 4;354(9181):803-9.

PMID:
10485721
[PubMed - indexed for MEDLINE]
20.

Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.

Estill J, Egger M, Blaser N, Vizcaya LS, Garone D, Wood R, Campbell J, Hallett TB, Keiser O; IeDEA Southern Africa.

AIDS. 2013 Jun 1;27(9):1483-92. doi: 10.1097/QAD.0b013e328360a4e5.

PMID:
23462219
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk